Daiichi Sankyo’s API Plant at Fukushima to Remain Offline Until September
06:17 AM | April 21, 2011 | Deepti Ramesh
Pharmaceutical company Daiichi Sankyo (Tokyo) says its Onahama plant in Fukushima prefecture, which produces active pharmaceutical ingredients (API), including pravastatin and olmesartan, is expected...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.